Pharmaceutical Wholesaling

Wholesalers of pharmaceutical products, clinical reagents, and medical instruments

I   Pharmaceutical Distribution/Wholesale Market Size and Company Ranking

1. Research Overview
2. Pharmaceutical Distribution/Wholesale Market Size

1. Sales of drugs and medicines
2. Sales of ethical drugs
3. Sales of non-prescription drugs

3. Pharmaceutical Wholesale Business

• Ranking of Total sales, ordinary profits, sales of drugs and medicines, sales of ethical drugs, sales of non-prescription drugs, sales per employee, etc.

II   Pharmaceutical Distributors/Wholesaler in Rapidly Changing Environment

• Favorable sales from special demands from drugs for treatment of hepatitis c infections
• Medipal Holdings and Alfresa Holdings: Limited favorable effects from hepatitis c treatment drugs
• Suzuken: Beneficial results by covering from Manufacturing to distribution
• Toho Holdings: Limited effects from special demands
• Rise in rate of reaching to agreement and improvement in distribution
• Rate of reaching to an agreement has attained almost 90%. Is it trustworthy?
• Can wholesalers solve the issues in these circumstances?
• Wholesaling after FY2016 Revision of Medical Treatment Fees
• The market volatility repeats
• Limited operation that relies on medicines
• Are there any ways for sustainable operation in the market environment where rapid changes are prospected?

III   Major Pharmaceutical Wholesaler Group Profiles

• Alfresa Holdings Corporation
• OHKI HEALTHCARE HOLDINGS CO., LTD.
• Suzuken Co., Ltd.
• TOHO HOLDINGS CO., LTD.
• VITAL KSK HOLDINGS, INC.
• Forest Holdings Inc.
• HOKUYAKU TAKEYAMA Holdings, Inc.
• MEDIPAL HOLDINGS CORPORATION
• HEREON Inc.

IV   Major Pharmaceutical Wholesaler Profiles

64 companies

V   Clinical Reagent/Medical Instrument Wholesaler Profiles

41 companies

VI   Pharmaceutical Wholesaler Data